| Human and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy G Churlaud, F Pitoiset, F Jebbawi, R Lorenzon, B Bellier, M Rosenzwajg, ... Frontiers in immunology 6, 171, 2015 | 238 | 2015 |
| A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques P Garrone, AC Fluckiger, PE Mangeot, E Gauthier, P Dupeyrot-Lacas, ... Science translational medicine 3 (94), 94ra71-94ra71, 2011 | 170 | 2011 |
| Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice G Darrasse-Jèze, AS Bergot, A Durgeau, F Billiard, BL Salomon, ... The Journal of clinical investigation 119 (9), 2648-2662, 2009 | 159 | 2009 |
| Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus–induced cryoglobulinemia vasculitis C Comarmond, M Garrido, S Pol, AC Desbois, M Costopoulos, ... Gastroenterology 152 (8), 2052-2062. e2, 2017 | 107 | 2017 |
| TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies T Courau, D Nehar-Belaid, L Florez, B Levacher, T Vazquez, F Brimaud, ... JCI insight 1 (9), 2016 | 104 | 2016 |
| Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins MC Serradell, LL Rupil, RA Martino, CG Prucca, PG Carranza, A Saura, ... Nature communications 10 (1), 361, 2019 | 98 | 2019 |
| Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses L Torrieri-Dramard, B Lambrecht, HL Ferreira, T Van den Berg, ... Molecular Therapy 19 (3), 602-611, 2011 | 97 | 2011 |
| DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant B Bellier, C Dalba, B Clerc, D Desjardins, R Drury, FL Cosset, M Collins, ... Vaccine 24 (14), 2643-2655, 2006 | 78 | 2006 |
| High diversity of the immune repertoire in humanized NOD.SCID.γc−/− mice G Marodon, D Desjardins, L Mercey, C Baillou, P Parent, M Manuel, ... European journal of immunology 39 (8), 2136-2145, 2009 | 65 | 2009 |
| Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines C Dalba, B Bellier, N Kasahara, D Klatzmann Molecular Therapy 15 (3), 457-466, 2007 | 64 | 2007 |
| Systems biology in vaccine design A Six, B Bellier, V Thomas‐Vaslin, D Klatzmann Microbial biotechnology 5 (2), 295-304, 2012 | 59 | 2012 |
| Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancer G Churlaud, V Jimenez, J Ruberte, MA Zin, G Fourcade, G Gottrand, ... Clinical Immunology 151 (2), 114-126, 2014 | 58 | 2014 |
| Low-dose IL-2 induces regulatory T cell–mediated control of experimental food allergy B Bonnet, J Vigneron, B Levacher, T Vazquez, F Pitoiset, F Brimaud, ... The Journal of Immunology 197 (1), 188-198, 2016 | 57 | 2016 |
| Enveloped virus-like particle platforms: vaccines of the future? F Pitoiset, T Vazquez, B Bellier Expert review of vaccines 14 (7), 913-915, 2015 | 49 | 2015 |
| Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms C Sedlik, J Vigneron, L Torrieri-Dramard, F Pitoiset, J Denizeau, ... Journal of extracellular vesicles 3 (1), 24646, 2014 | 47 | 2014 |
| Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice C Huret, D Desjardins, M Miyalou, B Levacher, MA Zin, O Bonduelle, ... Vaccine 31 (11), 1540-1547, 2013 | 45 | 2013 |
| DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies B Bellier, C Huret, M Miyalou, D Desjardins, MP Frenkiel, P Despres, ... Vaccine 27 (42), 5772-5780, 2009 | 39 | 2009 |
| Recombinant retrovirus‐like particle forming DNA vaccines in prime‐boost immunization and their use for hepatitis C virus vaccine development D Desjardins, C Huret, C Dalba, F Kreppel, S Kochanek, FL Cosset, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2009 | 39 | 2009 |
| The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation L Mascarell, S Airouche, N Berjont, C Gary, C Gueguen, G Fourcade, ... Mucosal immunology 10 (3), 695-704, 2017 | 38 | 2017 |
| Turning immunological memory into amnesia by depletion of dividing T cells B Bellier, V Thomas-Vaslin, MF Saron, D Klatzmann Proceedings of the National Academy of Sciences 100 (25), 15017-15022, 2003 | 37 | 2003 |
